Fullscript Announces Strategic Investment from Altas Partners and L Catterton
OTTAWA, Ontario--(BUSINESS WIRE)--Fullscript (the “Company”), a leading platform for practitioners delivering whole person care, today announced that L Catterton and Altas Partners (“Altas”) have agreed to acquire a majority stake in the Company from HGGC, LLC (“HGGC”) and Snapdragon Capital Partners, LLC (“Snapdragon”). The investment will help Fullscript further expand its platform and clinical support capabilities for practitioners and extend its reach across the North American healthcare market. Financial terms of the transaction were not disclosed.
Founded in 2011, Fullscript supports practitioners with an integrated platform providing access to data, diagnostic resources and tools they use to deliver more personalized, preventative care. Today, more than 135,000 healthcare practitioners use Fullscript to support care for 10 million patients annually across North America, with capabilities spanning evidence-based, practitioner-directed supplement recommendations and fulfillment, laboratory management, wearable health data integration and tools designed to improve patient adherence and outcomes.
“Practitioners are at the core of our business. We have built Fullscript around a simple belief: they should have the tools and information needed to see the whole patient and deliver better care. That belief will continue to guide how we grow. Altas and L Catterton share our conviction in where healthcare is headed, and their investment and experience will help us accelerate that vision,” said Kyle Braatz, CEO and co-founder of Fullscript. “We are grateful to HGGC and Snapdragon for the invaluable support over the last five years and are excited for the next chapter ahead.”
“The convergence of conventional and functional medicine is happening at a rapid pace. Millions of Americans are seeking trusted sources of education and treatment solutions to manage chronic conditions and prevent disease in order to live their healthiest life. Practitioners require a platform that can provide trusted whole-health protocols and products that is integrated into their daily practice management and assures safety and efficacy. Fullscript does just that. We are looking forward to helping the Fullscript team continue to build the most trusted and independent brand in all of whole-health care,” said Marc Magliacano, Managing Partner at L Catterton.
“Fullscript has become integral to healthcare practitioners by building a comprehensive platform around their evolving needs. Working alongside Kyle and the team, we will leverage our relationships and operating resources to build on Fullscript’s strong momentum, deepen practitioner support, and help more patients take a proactive approach to extending their healthspan,” Rajan Shah, Partner at L Catterton, added.
“Fullscript has established itself as a clear leader in whole-person care, with an exceptional management team and a differentiated model that position the company for significant continued growth,” said Paul Emery, Partner at Altas. “We have spent considerable time studying this market and have been particularly impressed by the strength of Fullscript’s platform, the trust it has earned from practitioners, and the critical role it plays in helping them care for their patients.”
Akshay Kumar, Partner at Altas, added, “We make a select number of investments each year and hold ourselves to a high bar. Fullscript is exactly the kind of exceptional company we look to partner with: a category leader with a mission-driven team and compelling growth potential. We’re excited to bring our experience supporting leading healthcare businesses to help Fullscript build on its momentum in the years ahead.”
“Over the course of our partnership, we have supported the Company’s evolution into a leading platform for practitioners delivering whole person care, including through investments in its clinical support capabilities, technology and growth initiatives,” said HGGC. “This transaction reflects the exceptional work of the Fullscript team and the meaningful value created through our partnership. We are proud of the Company’s progress and confident that Altas and L Catterton are well positioned to support Fullscript as it continues to advance its mission and pursue its next phase of growth.”
Fullscript enters this next phase with significant momentum across its platform. Most recently, University Hospitals became the latest major health system to integrate Fullscript into its Epic workflow, enabling providers to recommend clinician-grade supplements directly within the EHR. In April 2026, the Company launched Fullscript Journeys, which enables providers to deliver more personalized, consumer-grade health experiences while keeping clinical guidance at the center of care. In January 2026, Fullscript partnered with Oura to bring wearable biometric data directly into clinical workflows, giving providers a more complete view of their patients by bringing together wearable data, lab results and treatment history in one place. The Company’s 2024 acquisition of Rupa Health added advanced laboratory ordering and management tools, further expanding the breadth of the Fullscript platform.
Centerview Partners served as financial advisor to Fullscript. Evercore, Morgan Stanley & Co. LLC, and RBC Capital Markets served as financial advisors, and McDermott Will & Emery and Kirkland & Ellis served as legal counsel to both Altas and L Catterton. Jefferies LLC and William Blair served as financial advisors to HGGC and Snapdragon. The transaction is expected to close in the fourth quarter, subject to regulatory approvals and customary closing conditions.
About Fullscript
Founded in 2011, Fullscript is a leading platform for practitioners delivering whole person care. With a full suite of clinical support tools that make it easier for practices to deliver personalized care more efficiently and effectively – Fullscript has helped over 135,000 practitioners serving 10 million patients with seamless access to high-quality supplements, industry-leading labs, and smart adherence tools. For more information, visit Fullscript.com, or follow Fullscript on LinkedIn, Instagram, and Facebook.
About Altas Partners
Altas Partners is a North American private equity firm focused on selectively acquiring high-quality, durable businesses with compelling growth potential. The firm’s focused approach drives conviction and fosters deep partnerships with management teams and founders, with dedicated capabilities in operations, AI enablement, and talent to accelerate value creation. Founded in 2012, Altas operates from offices in Toronto and New York, is 100% partner-owned, and manages more than $10 billion on behalf of leading global institutional investors. For more information about Altas, please visit www.altas.com.
About L Catterton
L Catterton is the largest global consumer-focused investment firm, managing approximately $40 billion of equity capital across three multi-product platforms: private equity, credit, and real estate. The firm's funds have the ability to invest between $5 million and $5 billion, across the capital structure, in well-positioned consumer businesses. Leveraging deep category insight, operational excellence, and a broad network of strategic relationships, L Catterton's team of more than 200 investment and operating professionals across 18 offices partners with management teams to drive differentiated value creation across its portfolio. Founded in 1989, the firm has made over 300 investments in some of the world's most iconic consumer brands. For more information about L Catterton, please visit www.lcatterton.com.
About HGGC
HGGC is a values-driven, partnership-focused private investment firm. The Firm’s ecosystem of investors, operators, and professionals is united by the shared mission to develop leading enterprises and build long-term value together. HGGC invests in technology, business services, financial services, and consumer enterprises. The Firm is based in Palo Alto, Calif. and manages over $10 billion in assets under management as of March 31, 2026. More information, including a complete list of current and former investments, is available at www.hggc.com.
About Snapdragon
Founded in 2018, Snapdragon Capital Partners is a growth equity and buyout firm making concentrated investments. The firm has a distinguished reputation in partnering with consumer companies supporting whole person health, with relevant experience in fitness, vitamins & supplements, beauty, better-for-you foods, consumer health, and consumer education.
Contacts
Media Contacts
Fullscript
Heather Cameron
heather.cameron@fullscript.com
Altas Partners
Julie Rudnick
Altas@fgsglobal.com
L Catterton
Julie Hamilton
media@lcatterton.com
HGGC
Carly King / Madeline Jones
Joele Frank, Wilkinson Brimmer Katcher
HGGC-JF@joelefrank.com
(212) 355-4449